{"id":"NCT03165617","sponsor":"Seqirus","briefTitle":"Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age","officialTitle":"A Phase III/IV, Stratified, Randomized, Observer Blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of a Cell-Based Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Influenza Comparator Vaccine in Subjects ≥2 to <18 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-05-25","primaryCompletion":"2019-09-30","completion":"2019-09-30","firstPosted":"2017-05-24","resultsPosted":"2020-10-22","lastUpdate":"2020-10-22"},"enrollment":4514,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza, Human"],"interventions":[{"type":"BIOLOGICAL","name":"QIVc","otherNames":["Flucelvax Quadrivalent"]},{"type":"BIOLOGICAL","name":"Non-influenza Comparator Vaccine","otherNames":[]}],"arms":[{"label":"QIVc (≥2 years to <18 Years of Age)","type":"EXPERIMENTAL"},{"label":"Non-Influenza Comparator Vaccine","type":"ACTIVE_COMPARATOR"}],"summary":"This Phase 3/4, randomized, observer-blind, multi-center study, stratified study evaluated the immune (antibody) response, efficacy and safety of a cell-derived quadrivalent subunit influenza virus vaccine (Seqirus QIVc) in comparison with a non-influenza comparator, meningococcal serogroup A, C, W-135, and Y (Menveo®, GlaxoSmithKline Biologicals, S.A.) in healthy pediatric subjects ≥2 Years to \\<18 Years of Age","primaryOutcome":{"measure":"Primary Efficacy: First Occurrence of Either RT-PCR- or Culture-confirmed Influenza (Time-to-event Analyses) Due to Any Influenza Type A or B Strain Regardless of Antigenic Match to the Strains Selected for the Seasonal Vaccine in Subjects ≥2 to <18 Years","timeFrame":"Day 14 to Day 180 or until the end of the influenza season, whichever is longer","effectByArm":[{"arm":"QIVc (≥2 Years to <18 Years of Age)","deltaMin":175,"sd":null},{"arm":"Non-Influenza Comparator Vaccine","deltaMin":364,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":40,"countries":["Australia","Estonia","Finland","Lithuania","Philippines","Poland","Spain","Thailand"]},"refs":{"pmids":["34644472"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":2258},"commonTop":["Influenza like illness","Upper respiratory tract infection","Nasopharyngitis"]}}